pipette
ENEnglish

BNIP3L/NIX-mediated mitophagy limits Alzheimer disease pathology and preserves neuronal function

Y. Li, C. Ploumi, C. Volbracht, W. TIan, N. Kalogeraki, K. Kitopoulou, C. C. Navarro, Z. Li, N. Cherbuin, L. Camargo, Z. Ye, A. J. Nowak, S. Chintawar, M. Z. Cader, L. Berliocchi, S. Goletz, V. Bohr, K. Freude, K. Pakalikaras, L. Rasmussen

Preprint

En palabras de los autores

Defective mitophagy is emerging as a key contributor to Alzheimer disease (AD), but the neuronal pathways governing mitochondrial clearance and their contribution to disease progression remain poorly understood. Here, we identify BNIP3L/NIX-dependent mitophagy as a conserved neuronal quality control pathway that maintains mitochondrial fitness and constrains AD-associated proteotoxicity. Loss of BNIP3L/NIX or its C. elegans orthologue DCT-1 impaired basal and stressed-induced mitophagy, disrupted mitochondrial homeostasis, enhanced Tau and Amyloid-beta pathology and compromised neuronal network, synaptic and behavioral function across human neuronal and in vivo models. Conversely, restoring BNIP3L/NIX and DCT-1 activity improved neuronal function under proteotoxic stress in vivo, reduced disease-associated Tau phosphorylation in human neurons and markedly suppressed seeded Tau aggregation in primary mouse neurons. Together, these findings identify BNIP3L/NIX-mediated mitophagy as a mechanistic link between mitochondrial quality control, proteostasis and neuronal function, and establish its restoration as a potential strategy for counteracting AD-associated pathology.

Resultado principalEl resumen no menciona limitaciones.

Apareció: miércoles, 21 de octubre. bioRxiv. Preprint, todavía sin revisión por pares.

DOI: 10.64898/2026.10.18.759942